Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for hepatocellular carcinoma with chronic liver disease: a case report and review of literature.

Michail Papamichail, Michail Pizanias, Vincent Yip, Evangellos Prassas, Andreas Prachalias, Alberto Quaglia, Praveen Peddu, Nigel Heaton, Parthi Srinivasan
{"title":"Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for hepatocellular carcinoma with chronic liver disease: a case report and review of literature.","authors":"Michail Papamichail,&nbsp;Michail Pizanias,&nbsp;Vincent Yip,&nbsp;Evangellos Prassas,&nbsp;Andreas Prachalias,&nbsp;Alberto Quaglia,&nbsp;Praveen Peddu,&nbsp;Nigel Heaton,&nbsp;Parthi Srinivasan","doi":"10.14701/kjhbps.2016.20.2.75","DOIUrl":null,"url":null,"abstract":"<p><p>The incidence of complications after liver resection is closely related to functional future liver remnant (FLR). The standard approach to augment FLR is surgical or radiological occlusion of the artery or portal vein on the tumor side. Associated liver partition and portal vein ligation for staged hepatectomy (ALLPS) has been introduced as an alternative method to augment FLR. It offers rapid and effective hypertrophy for resecting liver metastases. However, data regarding its application in patients with hepatocellular carcinoma (HCC) with a background of chronic liver disease are limited. Here we describe the use of ALPPS procedure to manage a large solitary HCC with a background of chronic liver disease. The rising incidence of HCC has increased the number of surgical resections in patients with advanced stage liver disease not considered for liver transplantation. We reviewed reported experience of ALPPS in established chronic liver disease and current therapeutic modalities for HCC on a background of chronic liver disease in patients with potential liver insufficiency where tumor burden is beyond liver transplant criteria. </p>","PeriodicalId":91136,"journal":{"name":"Korean journal of hepato-biliary-pancreatic surgery","volume":"20 2","pages":"75-80"},"PeriodicalIF":0.0000,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.14701/kjhbps.2016.20.2.75","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean journal of hepato-biliary-pancreatic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14701/kjhbps.2016.20.2.75","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/5/11 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12

Abstract

The incidence of complications after liver resection is closely related to functional future liver remnant (FLR). The standard approach to augment FLR is surgical or radiological occlusion of the artery or portal vein on the tumor side. Associated liver partition and portal vein ligation for staged hepatectomy (ALLPS) has been introduced as an alternative method to augment FLR. It offers rapid and effective hypertrophy for resecting liver metastases. However, data regarding its application in patients with hepatocellular carcinoma (HCC) with a background of chronic liver disease are limited. Here we describe the use of ALPPS procedure to manage a large solitary HCC with a background of chronic liver disease. The rising incidence of HCC has increased the number of surgical resections in patients with advanced stage liver disease not considered for liver transplantation. We reviewed reported experience of ALPPS in established chronic liver disease and current therapeutic modalities for HCC on a background of chronic liver disease in patients with potential liver insufficiency where tumor burden is beyond liver transplant criteria.

Abstract Image

Abstract Image

Abstract Image

肝分区联合门静脉结扎治疗肝细胞癌合并慢性肝病的分期肝切除术(ALPPS) 1例报告及文献复习
肝切除术后并发症的发生率与功能性未来残肝(FLR)密切相关。增强FLR的标准方法是手术或放射阻断肿瘤一侧的动脉或门静脉。分期肝切除术(ALLPS)的相关肝分区和门静脉结扎已被引入作为增加FLR的替代方法。它为切除肝转移提供了快速有效的肥厚治疗。然而,关于其在慢性肝病背景的肝细胞癌(HCC)患者中的应用的数据有限。在这里,我们描述了使用ALPPS程序来处理具有慢性肝病背景的大型孤立性HCC。HCC发病率的上升增加了不考虑肝移植的晚期肝病患者手术切除的数量。我们回顾了ALPPS治疗慢性肝病的报道经验,以及目前HCC的治疗模式,其背景是慢性肝病中潜在肝功能不全患者的肿瘤负担超出肝移植标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信